<DOC>
	<DOCNO>NCT00942422</DOCNO>
	<brief_summary>RATIONALE : Green tea extract contain ingredient may prevent slow growth monoclonal gammopathy undetermined significance and/or smolder multiple myeloma . PURPOSE : This phase II trial study well green tea extract work treat patient monoclonal gammopathy undetermined significance and/or smolder multiple myeloma .</brief_summary>
	<brief_title>Green Tea Extract Treating Patients With Monoclonal Gammopathy Undetermined Significance and/or Smoldering Multiple Myeloma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Conduct pilot study investigate effect Polyphenon E , compound extract green tea contain epigallocatechin-3-gallate ( EGCG ) , monoclonal protein level patient monoclonal gammopathy undetermined significance and/or smolder multiple myeloma . Secondary - Collect , process , store blood marrow specimens future measurement biologic effect Polyphenon E plasma cell patient utilizing proteosome activity assay gene expression profile . OUTLINE : Patients receive oral green tea catechin extract ( Polyphenon E ) daily day 1-28 . Treatment repeat every 28 day 6 course absence disease progression unacceptable toxicity . Patients may undergo blood , urine , bone marrow sample collection periodically correlative laboratory study . Samples analyze monoclonal protein ( M-protein ) level , proteosome function , gene expression .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<mesh_term>Paraproteinemias</mesh_term>
	<mesh_term>Monoclonal Gammopathy Undetermined Significance</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Epigallocatechin gallate</mesh_term>
	<criteria>Measurable monoclonal protein serum ( immunoglobin [ Ig ] G IgM , &gt; = 1.0 g/dL use serum protein electrophoresis [ SPEP ] /immunofixation electrophoresis [ IFE ] ; IgA , SPEP/IFE confirm presence monoclonal IgA band plus quantitative IgA level &gt; = 750 mg/dL ) OR measurable urine Bence Jones paraprotein ( &gt; = 500mg/24hrs ) OR measurable serum free light chain ( FLC ) , define involve FLC level &gt; 10 mg/dl , serum FLC ratio abnormal Neutrophil count &gt; = 1,500 Platelet count &gt; = 100,000 Hemoglobin &gt; = 9mg/dL Alanine aminotransferase ( ALT ) = &lt; institutional upper limit normal ( IULN ) Aspartate aminotransferase ( AST ) = &lt; IULN Total bilirubin = &lt; IULN Alkaline phosphatase = &lt; IULN Any ethnic group Prior therapy allow &gt; = 4 week prior registration Life expectancy least 6 month Ability understand willingness sign write informed consent document Willingness comply oral home treatment visit schedule Patients reproductive capacity must willing use adequate contraception ( barrier contraception , birth control pill , highly effective hormonal agent ) abstain sexual activity duration study 30 day beyond end therapy Pregnant woman Breastfeeding woman Confirmed symptomatic multiple myeloma ( MM ) , define follow : Lytic lesion skeletal survey Anemia attributable plasma cell infiltrate marrow Hypercalcemia Renal dysfunction attributable cause Uncontrolled intercurrent illness , include limited active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness social situation would compromise compliance study medication follow visit Patients high predisposition gastrointestinal bleeding , know gastroesophageal varix active peptic ulcer disease Patients chronic liver disease ( hepatitis B , hepatitis C , alcoholic cirrhosis ) Prior daily ingestion green tea green tea extract within 6 month study entry Patients previously experience adverse symptom relate green tea inactive component present Polyphenon E capsule Concurrent use investigational commercial agent therapy intent treat MGUS and/or SMM</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>monoclonal gammopathy undetermined significance</keyword>
	<keyword>smolder multiple myeloma</keyword>
</DOC>